文献速递心外重症与机械循环支持

心源性休克患者股动静脉VA-ECMO经皮与外科插管的比较:体外生命支持组织登记研究结果

Percutaneous versus surgical cannulation for femoro-femoral VA-ECMO in patients with cardiogenic shock: Results from the Extracorporeal Life Support Organization Registry.
PubMed 文献 · J Heart Lung Transplant · 2022-01-10

基于体外生命支持组织国际登记数据,纳入2008年1月至2019年12月接受股动静脉VA-ECMO的成年难治性心源性休克患者12,592例,其中9,249例(73%)经皮插管。经皮插管与住院死亡率、插管部位出血和全身感染率更低独立相关,严重肢体缺血在调整分析中无显著差异。

要点

  • 经皮插管比例从研究期间的32%升至84%(趋势p<0.01)。
  • 经皮组住院死亡率53% vs 外科组58%(p<0.01),插管部位出血19% vs 22%(p<0.01),全身感染8% vs 15%(p<0.01)。
  • 调整后经皮插管与住院死亡率(OR 0.76;95%CI 0.70-0.84;p<0.01)、插管部位出血(OR 0.70;95%CI 0.60-0.80;p<0.01)和全身感染(OR 0.63;95%CI 0.54-0.74;p<0.01)更低独立相关。

核心结论

  • 与外科插管相比,经皮插管与更低的住院死亡率和更少的并发症独立相关。

研究设计与样本

  • 回顾性分析国际体外生命支持组织登记数据,纳入2008年1月至2019年12月接受股动静脉VA-ECMO的成年难治性心源性休克患者12,592例,其中经皮组9,249例(73%),外科组为其余患者。

主要发现

  • 经皮插管比例从32%上升至84%(趋势p<0.01)。
  • 经皮组 vs 外科组:住院死亡率53% vs 58%(p<0.01),插管部位出血19% vs 22%(p<0.01),全身感染8% vs 15%(p<0.01)。
  • 严重肢体缺血经皮组5% vs 外科组3%(p<0.01),但调整分析无显著差异(OR 1.28;95%CI 0.93-1.62;p=0.15)。

关键数值与推荐

  • 调整后经皮插管与住院死亡率更低独立相关(OR 0.76;95%CI 0.70-0.84;p<0.01)。
  • 调整后经皮插管与插管部位出血更低独立相关(OR 0.70;95%CI 0.60-0.80;p<0.01)。
  • 调整后经皮插管与全身感染更低独立相关(OR 0.63;95%CI 0.54-0.74;p<0.01)。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PURPOSE: Percutaneous cannulation is increasingly used for veno-arterial extracorporeal membrane oxygenation (VA-ECMO). However, there is limited evidence about the benefit of this approach compared with conventional surgical cannulation. By using a large international database, this study was designed to compare in-hospital outcomes in cardiac shock patients who received femoro-femoral VA-ECMO with percutaneous versus surgical cannulation. METHODS: Adults with refractory cardiogenic shock treated with percutaneous (percutaneous group) or surgical (surgical group) femoro-femoral VA-ECMO between January 2008 and December 2019 were extracted from the international Extracorporeal Life Support Organization registry. The primary outcome was in-hospital mortality. Multivariable logistic regression analyses were performed to assess the association between percutaneous cannulation and in-hospital outcomes. RESULTS: Among 12,592 patients meeting study inclusion, 9,249 (73%) underwent percutaneous cannulation. The proportion of patients undergoing percutaneous cannulation increased from 32% to 84% over the study period (p < 0.01 for trend). In-hospital mortality (53% vs 58%; p < 0.01), cannulation site bleeding (19% vs 22%; p < 0.01), and systemic infection (8% vs 15%; p < 0.01) occurred less frequently in the percutaneous group compared to the surgical group. In adjusted analyses, percutaneous cannulation was independently associated with lower rates of in-hospital mortality (odds ratio [OR] 0.76; 95% CI 0.70-0.84; p < 0.01), cannulation site bleeding (OR 0.70; 95% CI 0.60-0.80; p < 0.01) and systemic infection (OR, 0.63; 95% CI 0.54-0.74; p < 0.01). Severe limb ischemia was more frequently observed in the percutaneous group (5% vs 3%; p < 0.01). However, this association was not significant in adjusted analysis (OR 1.28; 95% CI 0.93-1.62; p = 0.15). CONCLUSIONS: Compared with surgical cannulation, percutaneous cannulation was independently associated with lower in-hospital mortality and fewer complications.

来源:J Heart Lung Transplant,查看原文。版权归原作者所有。

引用

  1. Wang L, Yang F, Zhang S, et al. Percutaneous versus surgical cannulation for femoro-femoral VA-ECMO in patients with cardiogenic shock: Results from the Extracorporeal Life Support Organization Registry. J Heart Lung Transplant. 2022. PMID: 35125287. doi:10.1016/j.healun.2022.01.009

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。